Search for the latest oncology news by tumour type
New results for higher dose level cohorts of the investigational study REGN5458 (BCMAxCD3) bispecific antibody,…
In an early benefit assessment, the German Institute for Quality and Efficiency in Health Care…
Young patients with chronic lymphocytic leukaemia (CLL) can enjoy long remissions on the drug ibrutinib, but must stay on it indefinitely to…
A drug combination can safely prevent transplanted stem cells (graft) from attacking the recipient’s (host)…
A new study led by João T. Barata from Instituto de Medicina Molecular João Lobo…
Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim…
In a phase III trial, a combination of ivosidenib and azacitidine was found superior in…
A study of nearly 25,000 young people with ALL reveals significant gaps in survival rates…
Two-year data from the ZUMA-7 trial primary analysis show that the CAR T-cell therapy axicabtagene…
Patients receiving the anti-CD38 monoclonal antibody isatuximab in addition to the standard three- component induction…